返回顶部
返回首页 会员充值 我的足迹 返回上一页

Precision AQ:2024生物医药企业全渠道营销现状报告(英文版)(43页).pdf

2024-12-30
文档编号:630502
文档页数:43
文档大小:24.38MB
下载积分:VIP专享
文档格式:PDF 中文版 PPTX

1、R E P O R TTHE STATE OF OMNICHANNELIN BIOPHARMA2024INSIGHTS AND HIGHLIGHTS FROM OUR NAVIGATOR365TMAND MATUROMETERTMRESEARCH2CONFIDENTIAL|Precision AQ,LLC.All rights reserved.THE STATE OF OMNICHANNELIN BIOPHARMA2024HCPLAUNCHBENCHMARKINDUSTRYPAYERTHE STATE OF OMNICHANNELIN BIOPHARMA2024_Navigator365_I

2、ntroduction_HCP_LAUNCHBENCHMARK_INDUSTRY_PAYER_CHANNELS_About us_Contact us2CONFIDENTIAL|Precision AQ,LLC.All rights reserved.Welcome to our latest annual trends report on the state of omnichannel customer engagement in biopharma wehope you enjoy the new look!In this report,we aim to share some of 2

3、024s most interesting insights and trends pulled from our Navigator365 and Maturometer research,to create a unique snapshot of what biopharma and its HCP and Payer audiences have been thinking and doing in the omnichannel space.We look forward to hearing your thoughts!Ruud KooiHCPLAUNCHBENCHMARKINDU

4、STRYPAYERCHANNELSAbout usIntroductionHCP ENGAGEMENTOMNICHANNEL LAUNCH TRENDSBENCHMARK ANALYSISINDUSTRY PERFORMANCEPAYER HIGHLIGHTSCHANNEL METRICSAbout Navigator365TMContact usTHE STATE OF OMNICHANNELIN BIOPHARMA2024EVP,Managing Director Omnichannel SolutionsPrecision AQ The new name for Across Healt

5、h345151823293441433CONFIDENTIAL|Precision AQ,LLC.All rights reserved.THE STATE OF OMNICHANNELIN BIOPHARMA2024HCPLAUNCHBENCHMARKINDUSTRYPAYERTHE STATE OF OMNICHANNELIN BIOPHARMA2024_Navigator365_Introduction_HCP_LAUNCHBENCHMARK_INDUSTRY_PAYER_CHANNELS_About us_Contact us3CONFIDENTIAL|Precision AQ,LLC

6、.All rights reserved.THE STATE OF OMNICHANNELIN BIOPHARMA2024About usAcross Health,along with the entire Precision Value&Health team(of which we have been a part since February 2021),is now unified under one name:Precision AQ.This new brand marks a pivotal moment as it unites Across Health with all

Precision AQ:2024生物医药企业全渠道营销现状报告(英文版)(43页).pdf_第1页
Precision AQ:2024生物医药企业全渠道营销现状报告(英文版)(43页).pdf_第2页
Precision AQ:2024生物医药企业全渠道营销现状报告(英文版)(43页).pdf_第3页
Precision AQ:2024生物医药企业全渠道营销现状报告(英文版)(43页).pdf_第4页
Precision AQ:2024生物医药企业全渠道营销现状报告(英文版)(43页).pdf_第5页

点击查看更多